245 related articles for article (PubMed ID: 17198074)
1. Markedly elevated serum CA 19-9 levels in association with a benign biliary stricture due to primary sclerosing cholangitis.
Murray MD; Burton FR; Di Bisceglie AM
J Clin Gastroenterol; 2007 Jan; 41(1):115-7. PubMed ID: 17198074
[TBL] [Abstract][Full Text] [Related]
2. Diagnosis of biliary strictures in conjunction with endoscopic retrograde cholangiopancreaticography, with special reference to patients with primary sclerosing cholangitis.
Lindberg B; Arnelo U; Bergquist A; Thörne A; Hjerpe A; Granqvist S; Hansson LO; Tribukait B; Persson B; Broomé U
Endoscopy; 2002 Nov; 34(11):909-16. PubMed ID: 12430077
[TBL] [Abstract][Full Text] [Related]
3. Impact of dominant stenoses on the serum level of the tumor marker CA19-9 in patients with primary sclerosing cholangitis.
Petersen-Benz C; Stiehl A
Z Gastroenterol; 2005 Jun; 43(6):587-90. PubMed ID: 15986288
[TBL] [Abstract][Full Text] [Related]
4. The utility of CA 19-9 in the diagnoses of cholangiocarcinoma in patients without primary sclerosing cholangitis.
Patel AH; Harnois DM; Klee GG; LaRusso NF; Gores GJ
Am J Gastroenterol; 2000 Jan; 95(1):204-7. PubMed ID: 10638584
[TBL] [Abstract][Full Text] [Related]
5. Cholangiocarcionoma and primary sclerosing cholangitis: the answer lies within.
Shah RJ
Gastrointest Endosc; 2014 May; 79(5):780-2. PubMed ID: 24721627
[No Abstract] [Full Text] [Related]
6. Endoscopic retrograde cholangiopancreatography in diagnosis and treatment of primary sclerosing cholangitis.
Gotthardt D; Stiehl A
Clin Liver Dis; 2010 May; 14(2):349-58. PubMed ID: 20682240
[TBL] [Abstract][Full Text] [Related]
7. Is a raised CA 19-9 level diagnostic for a cholangiocarcinoma in patients with no history of sclerosing cholangitis ?
John AR; Haghighi KS; Taniere P; Esmat ME; Tan YM; Bramhall SR
Dig Surg; 2006; 23(5-6):319-24. PubMed ID: 17170527
[TBL] [Abstract][Full Text] [Related]
8. [The use of endoscopic method in treatment of strictures of biliary tree].
Wojtuń S; Gil J; Zyśko B
Pol Merkur Lekarski; 2007 May; 22(131):477-81. PubMed ID: 17679400
[TBL] [Abstract][Full Text] [Related]
9. Temporary resolution of obstructive jaundice during ursodeoxycholic acid therapy in a patient with primary sclerosing cholangitis and a dominant biliary stricture.
Fracchia M; Soubrane O; Houssin D; Galatola G
Ital J Gastroenterol; 1995; 27(8):430-5. PubMed ID: 8775469
[TBL] [Abstract][Full Text] [Related]
10. Astronomically high CA 19-9 in a patient with a benign lesion.
Rao NA; Satyaprakash BS
S Afr J Surg; 2013 Oct; 51(4):151. PubMed ID: 24209706
[No Abstract] [Full Text] [Related]
11. Primary sclerosing cholangitis: patients with a rising alkaline phosphatase at annual follow-up.
Charatcharoenwitthaya P; Lindor KD
Clin Gastroenterol Hepatol; 2007 Jan; 5(1):32-6. PubMed ID: 17234554
[No Abstract] [Full Text] [Related]
12. Primary sclerosing cholangitis with equivocal cytology: fluorescence in situ hybridization and serum CA 19-9 predict risk of malignancy.
Barr Fritcher EG; Voss JS; Jenkins SM; Lingineni RK; Clayton AC; Roberts LR; Halling KC; Talwalkar JA; Gores GJ; Kipp BR
Cancer Cytopathol; 2013 Dec; 121(12):708-17. PubMed ID: 23839915
[TBL] [Abstract][Full Text] [Related]
13. Cholangioscopic characterization of dominant bile duct stenoses in patients with primary sclerosing cholangitis.
Tischendorf JJ; Krüger M; Trautwein C; Duckstein N; Schneider A; Manns MP; Meier PN
Endoscopy; 2006 Jul; 38(7):665-9. PubMed ID: 16673310
[TBL] [Abstract][Full Text] [Related]
14. False elevation of CA 19-9 levels in a patient with a history of pancreatic cancer.
Goetz M; Steen PD
Am J Gastroenterol; 1997 Aug; 92(8):1390-1. PubMed ID: 9260821
[TBL] [Abstract][Full Text] [Related]
15. Severe acute pancreatitis as the presenting symptom of primary sclerosing cholangitis: treatment by endoscopic insertion of a biliary stent.
Goldin E; Libson E; Wengrower D; Antal S; Kovacs Z; Rachmilewitz D
Int Surg; 1990; 75(1):58-60. PubMed ID: 2318575
[TBL] [Abstract][Full Text] [Related]
16. IgG4 negative sclerosing cholangitis associated with autoimmune pancreatitis.
Sewkani A; Kapoor S; Sharma S; Naik S; Debbarma MK; Varshney S
JOP; 2005 May; 6(3):269-73. PubMed ID: 15883479
[TBL] [Abstract][Full Text] [Related]
17. Primary sclerosing cholangitis, chronic ulcerative colitis, and bile duct dysplasia--Case presentation.
Narayanan Menon KV
Liver Transpl; 2006 Nov; 12(11 Suppl 2):S14. PubMed ID: 17051557
[No Abstract] [Full Text] [Related]
18. IgG4-related retroperitoneal fibrosis and sclerosing cholangitis independent of autoimmune pancreatitis. A recurrent case after a 5-year history of spontaneous remission.
Miura H; Miyachi Y
JOP; 2009 Jul; 10(4):432-7. PubMed ID: 19581751
[TBL] [Abstract][Full Text] [Related]
19. Spindle cell carcinoma of the intrahepatic bile duct in a patient with primary sclerosing cholangitis.
Shinoda M; Shimazu M; Mukai M; Tanabe M; Hashiguchi N; Oda M; Kitajima M
J Gastroenterol; 2003; 38(11):1091-6. PubMed ID: 14673729
[TBL] [Abstract][Full Text] [Related]
20. Biliary obstruction induces extremely elevated serum CA 19-9 levels: case report.
Onal C; Colakoglu T; Ulusan SN; Yapar AF; Kayaselcuk F
Onkologie; 2012; 35(12):780-2. PubMed ID: 23207625
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
